Skip to main content

Katerzia Side Effects

Generic name: amlodipine

Medically reviewed by Last updated on Oct 11, 2023.

Note: This document contains side effect information about amlodipine. Some dosage forms listed on this page may not apply to the brand name Katerzia.

Applies to amlodipine: oral solution, oral suspension, oral tablet.

Serious side effects of Katerzia

Along with its needed effects, amlodipine (the active ingredient contained in Katerzia) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor immediately if any of the following side effects occur while taking amlodipine:

More common

Less common


Incidence not known

Other side effects of Katerzia

Some side effects of amlodipine may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.

Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

Less common


Incidence not known

For Healthcare Professionals

Applies to amlodipine: oral liquid, oral suspension, oral tablet, oral tablet disintegrating.


The most commonly reported side effects include headache, edema, rash, fatigue, and dizziness.[Ref]


Very common (10% or more): Edema (up to 14.6%)

Common (1% to 10%): Palpitations, ankle edema

Uncommon (0.1% to 1%): Hypotension, chest pain

Very rare (less than 0.01%): Myocardial infarction, arrhythmia (including bradycardia, ventricular tachycardia, atrial fibrillation), vasculitis, cardiac failure, pulse irregularity, extrasystoles, hot flush

Frequency not reported: Tachycardia, peripheral ischemia, postural hypotension[Ref]

Myocardial infarction, chest pain, and arrhythmia (e.g., bradycardia, ventricular tachycardia, atrial fibrillation) cannot be distinguished from the natural history of the underlying disease.

Edema occurred in 14.6% of female patients given this drug compared to 5.6% of male patients, and was more likely to occur in patients given the 10 mg dose (compared to the 5 and 2.5 mg doses).[Ref]

Nervous system

Common (1% to 10%): Somnolence, dizziness, headache

Uncommon (0.1% to 1%): Tremor, taste perversion/dysgeusia, syncope, hypoesthesia, paresthesia

Very rare (less than 0.01%): Hypertonia, peripheral neuropathy, ataxia, migraine, amnesia, parosmia

Frequency not reported: Extrapyramidal syndrome, postural dizziness, vertigo[Ref]

Headache occurred commonly during clinical trials, especially at the beginning of treatment.

Extrapyramidal syndrome may be associated with this drug.[Ref]


Common (1% to 10%): Abdominal pain, nausea

Uncommon (0.1% to 1%): Vomiting, dyspepsia, altered bowel habits (including diarrhea and constipation), dry mouth

Very rare (less than 0.01%): Pancreatitis, gastritis, gingival hyperplasia, loose stools

Frequency not reported: Dysphagia, flatulence[Ref]


Common (1% to 10%): Flushing

Uncommon (0.1% to 1%): Alopecia, skin discoloration, increased sweating/hyperhidrosis, pruritus, rash, exanthema

Very rare (less than 0.01%): Erythema multiforme, urticaria, exfoliative dermatitis, Stevens-Johnson syndrome, Quincke edema, photosensitivity, skin dryness, cold and clammy skin, dermatitis[Ref]


Common (1% to 10%): Fatigue

Uncommon (0.1% to 1%): Tinnitus, asthenia, pain, malaise

Frequency not reported: Rigors, thirst[Ref]


Uncommon (0.1% to 1%): Micturition disorder, nocturia, increased urinary frequency, impotence

Very rare (less than 0.01%): Dysuria, polyuria

Frequency not reported: Male/female sexual dysfunction[Ref]


Uncommon (0.1% to 1%): Arthralgia, myalgia, muscle cramps, back pain

Very rare (less than 0.01%): Muscle weakness

Frequency not reported: Arthrosis, twitching[Ref]


Uncommon (0.1% to 1%): Insomnia, mood changes (including anxiety), depression

Rare (0.01% to 0.1%): Confusion

Frequency not reported: Abnormal dreams, depersonalization, nervousness, apathy, agitation[Ref]


Uncommon (0.1% to 1%): Dyspnea, rhinitis

Very rare (less than 0.01%): Cough

Frequency not reported: Epistaxis[Ref]


Uncommon (0.1% to 1%): Visual disturbance (including diplopia)

Very rare (less than 0.01%): Abnormal visual accommodation, xerophthalmia

Frequency not reported: Abnormal vision, conjunctivitis, eye pain[Ref]


Uncommon (0.1% to 1%): Weight increase/decrease

Very rare (less than 0.01%): Hyperglycemia, increased appetite

Frequency not reported: Anorexia[Ref]


Uncommon (0.1% to 1%): Purpura

Very rare (less than 0.01%): Leukopenia, thrombocytopenia[Ref]


Uncommon (0.1% to 1%): Gynecomastia[Ref]


Very rare (less than 0.01%): Hepatitis, jaundice, hepatic enzymes increased[Ref]

Increased hepatic enzymes were mostly consistent with cholestasis.

Some cases of hepatitis, jaundice, and/or hepatic enzyme elevations were severe enough to require hospitalization; however, the association with this drug was uncertain in most cases.[Ref]


Very rare (less than 0.01%): Allergic reactions, angioedema[Ref]

Frequently asked questions


1. Product Information. Norvasc (amlodipine). Pfizer U.S. Pharmaceuticals. 2002;PROD.

2. Cerner Multum, Inc. UK Summary of Product Characteristics.

3. Cerner Multum, Inc. Australian Product Information.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.